Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.

Sophia Seo-hyeon Lee,Deborah McCue,Naveen Pemmaraju

Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.

2020

Sophia Seo-hyeon Lee
Deborah McCue
Naveen Pemmaraju

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy that previously lacked standardized therapeutic approaches. CD123 (interleukin-3 receptor alpha uni...

Keywords:

Receptor
Interleukin-3 receptor
Leukemia
Blastic plasmacytoid dendritic cell neoplasm
Pathology
Hematologic malignancy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations